Second-generation CT scanner substantially reduces radiation exposure

January 31, 2013 in Cancer

Researchers using a newly approved advanced computed tomography (CT) system were able to significantly reduce radiation exposure in patients undergoing coronary CT angiography (CCTA), according to a new study published online in the journal Radiology.

" during diagnostic imaging is a substantial public concern," said Marcus Y. Chen, M.D., lead author of the study from the advanced cardiovascular imaging laboratory at the National Institutes of Health in Bethesda, Md. "Minimizing radiation exposure while maintaining diagnostic-quality scans is clearly feasible with this new second-generation 320–detector row CT scanner."

CCTA is a valuable noninvasive imaging exam with high . The exam is particularly effective and safe for the exclusion of significant in patients arriving at the emergency department with . However, the clinical benefit of CCTA has been tempered by concerns of potential future cancer risk from the radiation exposure. Technologic advances have evolved to allow radiologists to not only reduce radiation exposure to the patient but also to improve image ac¬quisition.

This study represents the initial coronary angiography results obtained with a prototype 320–detector row CT system recently approved by the U.S. . The new system holds several technical advantages over its first-generation counterpart, including a gantry rotation time of 275 milliseconds, wide volume coverage, iterative reconstruction, automated exposure control, and a larger x-ray power generator.

For the study, Dr. Chen and colleagues performed contrast–enhanced CCTA with a second-generation 320-slice CT system on 107 adult patients (mean age, 55.4) and compared radiation exposure and image quality to those of CCTA exams previously performed on 100 patients using a first-generation 320-slice scanner.

Effective radiation dose was estimated by multiplying the dose-length product—a calculation of the radiation dose for a series of scans or entire examination—by an effective dose conversion factor and reported with size-specific dose estimates (SSDEs). Image quality was evaluated by two independent readers.

The median radiation dose was 0.93 millisieverts (mSv) with the second-generation unit and 2.67 mSv with the first-generation unit. The median SSDE was 6.0 milligray (mGy) with the second-generation unit and 13.2 mGy with the first-generation unit. Overall, the radiation dose was less than 0.5 mSv for 23 of the 107 CT angiography examinations (21.5 percent), less than 1 mSv for 58 (54.2 percent), and less than 4 mSv for 103 (96.3 percent). All studies were of diagnostic quality, with most having excellent image quality.

"The second-generation provided excellent image quality over a wide range of body sizes and heart rates at low radiation doses," Dr. Chen said. "The low dose achieved during CT angiography could be used to minimize overall to the patient or to enable addi¬tional types of imaging within reasonable radiation doses."

Journal reference: Radiology search and more info website

Provided by Radiological Society of North America search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

New fluorescent tools for cancer diagnosis

In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...

Cancer created 14 hours ago | popularity not rated yet | comments 0

Modulating the immune system to combat metastatic cancer

Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...

Cancer created 14 hours ago | popularity 5 / 5 (1) | comments 0

Scientists put bowel cancer under the microscope

Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.

Cancer created 18 hours ago | popularity 5 / 5 (1) | comments 0

Researcher identifies breast cancer fighting hormone

Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.

Cancer created 18 hours ago | popularity 5 / 5 (2) | comments 0

Ground breaking cancer research finds immune system link

(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.

Cancer created 19 hours ago | popularity 5 / 5 (4) | comments 0


Engineered cytomegalovirus protects monkeys from HIV equivalent

(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...

Help at hand for people with schizophrenia

How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.

Alzheimer's disease, the soft target of the euthanasia debate

(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.